A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers
PHASE1Not yet recruitingINTERVENTIONAL
Enrollment
44
Participants
Timeline
Start Date
December 31, 2025
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG
AD-116
AD-116 Oral Tablet
DRUG
AD-1161
AD-1161 Oral Capsule
All Listed Sponsors
lead
Addpharma Inc.
INDUSTRY
NCT07103278 - A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers | Biotech Hunter | Biotech Hunter